Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in Taiwan

Key Points

• The aim is to evaluate the persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis in a real-world context.
• Real-world observational study
• Analysis of treatment patterns over time
• Involvement of patients with plaque psoriasis
• Indicated high persistence rates of interleukin-17 and interleukin-23 inhibitors
• Potential implications for long-term management in plaque psoriasis
• Support for informed clinical decision-making in healthcare settings